3 Recruiting Endometrial Neoplasms Phase 3 Clinical Trials

Active phase 3 studies for endometrial neoplasms enrolling across the USA. Verify eligibility and contact site coordinators.

All Endometrial Neoplasms studies

Phase 3 Studies for Endometrial Neoplasms

🔵 Active, Not Recruiting Phase3

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

📍 Research Site — Tucson, Arizona

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama

View Study & Checklist ➔